Article Details

Sparrow Pharmaceuticals Secures $50 Million Series A Financing

Retrieved on: 2021-05-18 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Sparrow Pharmaceuticals Secures $50 Million Series A Financing. View article details on hiswai:

Excerpt

OrbiMed led the investment round with participation by RiverVest Venture Partners and U.S. Venture Partners (USVP). This financing will allow the ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up